Company:  HARVARD BIOSCIENCE INC (HBIO)
Form Type:  10-Q
Filing Date:  11/8/2019 
CIK:  0001123494 
Address:  84 OCTOBER HILL RD 
City, State, Zip:  HOLLISTON, Massachusetts 01746 
Telephone:  (508) 893-8999 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$3.35  
Change: 
0.10 (3.08%)  
Trade Time: 
10:14 AM EST  
Market Cap: 
$127.52M
Trade HBIO now with 

© 2019  
Description of Business
Harvard Bioscience, Inc., a Delaware corporation, is a global developer, manufacturer, marketer and provider of a broad range of scientific instruments, systems, software and services used to advance life science for basic research, drug discovery, physiologic monitoring, clinical and environmental testing. Our products and services are sold to thousands of researchers in over 100 countries through our global sales organization, websites, catalogs, and through distributors including Thermo Fisher Scientific Inc., VWR and other specialized distributors. We have sales and manufacturing operations in the United States, the United Kingdom, Germany, Sweden, Spain, France, Canada, Italy and China. Our History Our business began in 1901 under the name Harvard Apparatus. It was founded by Dr. William T. Porter, a Professor of Physiology at Harvard Medical School and a pioneer of physiology education.
Register and access this filing in:     
  FORM 10-Q
    PART I. FINANCIAL INFORMATION
      Item 1. Financial Statements.
        BALANCE SHEET
        INCOME STATEMENT
        STOCKHOLDERS EQUITY
        CASH FLOW
        NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
      Item 2. Management's Discussion and Analysis of Financial ...
      FINANCIAL STATEMENTS
        CASH FLOW
      Item 3. Quantitative and Qualitative Disclosures about ...
      Item 4. Controls and Procedures.
    PART II. OTHER INFORMATION
      Item 1A. Risk Factors.
      Item 6. Exhibits
    SIGNATURES
    INDEX TO EXHIBITS
  EXHIBIT 31.1
    Certification
  EXHIBIT 31.2
    Certification
  EXHIBIT 32.1
    CERTIFICATION OF PERIODIC FINANCIAL REPORT
  EXHIBIT 32.2
    CERTIFICATION OF PERIODIC FINANCIAL REPORT